Malacoplakia

Malacoplakia is a condition where soft, bumpy patches form on the lining of organs like the bladder or intestines. It's usually caused by an infection. These patches are made of calcium deposits. It's not contagious and often doesn't cause symptoms, but sometimes it can lead to problems.

Condition

What people with Malacoplakia report

Every report comes from a Lived member, sent anonymously.

Have you tried Cipro (Ciprofloxacin) for Malacoplakia?

NameHow it went

About Malacoplakia

What It Is

Malacoplakia (also spelled malakoplakia) is a rare, long-lasting inflammatory condition that forms soft, raised, yellowish patches or lumps in the body's tissues. The name comes from Greek words meaning "soft plaque." It develops when macrophages, the immune cells that swallow and destroy bacteria, cannot finish breaking them down. Partly digested bacteria build up inside these cells, and the tissue around them stays inflamed. The bladder and the rest of the urinary tract are the most common sites, but malacoplakia can also appear in the colon, rectum, appendix, kidneys, skin, lungs and many other organs. What it causes depends on where it is: urinary symptoms in the bladder, bowel symptoms in the colon, a firm lump or sore on the skin. Because it can form a mass, it is often first mistaken for cancer.

Causes & Risk Factors

Malacoplakia nearly always develops alongside a bacterial infection, most often E. coli, the bacterium behind most urinary tract infections. Many people have had repeated or hard-to-clear infections before it is found. The underlying problem is thought to be a defect in how macrophages kill bacteria rather than an unusually aggressive germ. Weakened immunity is the strongest known risk factor. It is seen more often in people who have had an organ transplant (especially a kidney transplant), and in people taking corticosteroids or chemotherapy, or living with cancer, HIV, poorly controlled diabetes, tuberculosis or long-term heavy alcohol use. It can also occur in people with no obvious immune problem. It most commonly affects middle-aged adults, and women are affected more often than men. It is not contagious.

How It's Diagnosed

Diagnosis starts with symptoms and whatever the first tests show: blood in the urine, a mass on a CT scan or ultrasound, or a growth seen through a cystoscope (a thin camera passed into the bladder) or colonoscope. Urine or tissue cultures often grow E. coli or a related bacterium. Imaging alone cannot tell malacoplakia apart from a tumor, so it cannot confirm the diagnosis. A biopsy settles it. Under the microscope, a pathologist looks for sheets of swollen macrophages containing small, layered, mineral-coated deposits called Michaelis-Gutmann bodies, which are the hallmark of the disease. The pathologist also rules out conditions that can look similar, such as cancer, tuberculosis and Crohn's disease. When a mass is found, a biopsy before major surgery can prevent an unnecessary operation for a cancer that is not there.

Treatment Options

There are no clinical trials or formal guidelines for malacoplakia; treatment is based on published case reports and specialist experience. The main treatment is a long course of antibiotics chosen because they can get inside macrophages and help them clear the bacteria. Fluoroquinolones such as ciprofloxacin and trimethoprim-sulfamethoxazole (Bactrim) are the drugs most often used, with the choice guided by culture results. Courses usually last weeks to months, so side effects from the antibiotic itself are part of what the care team watches for. Some doctors add bethanechol, a medicine that may help macrophages work better, or vitamin C, though evidence for either is limited. For people who have had a transplant or take other immune-suppressing medicines, the specialist team usually lowers those medicines where it is safe to do so, alongside antibiotics. In published kidney transplant cases, this combination improved or cleared most cases. Surgery is used when antibiotics are not enough, when a lesion blocks the flow of urine or bowel contents, or when cancer cannot be ruled out. This might mean removing an affected area of bladder, bowel or skin, or placing a tube or stent to drain a blocked kidney. In transplant recipients, cases managed without removing the mass tended to do better, so surgery is generally kept for when it is clearly needed.

What to Expect

Many people improve with antibiotics, and lumps often shrink over weeks to months. The course varies with where the disease is, how much tissue is involved and how well the immune system is working. Treatment can be long, and some people need more than one round. Malacoplakia can come back, especially in people whose immunity remains weakened, so follow-up continues after symptoms settle. For urinary tract disease this usually means repeat imaging and cystoscopy at intervals; for other sites, imaging or scope checks as the specialist advises. Kidney function is monitored when the urinary tract is involved, because disease that blocks urine flow can cause lasting kidney damage if it is not treated. Serious complications such as widespread infection are uncommon but are more likely when diagnosis is delayed in someone with weakened immunity.

When to Seek Help

See a clinician if you have urinary tract infections that keep coming back or will not clear, blood in your urine, persistent flank pain, rectal bleeding, ongoing changes in bowel habits, or a lump or sore that does not heal, especially if you have had a transplant or take immune-suppressing medicine. If you are being treated for malacoplakia, contact your care team the same day if you develop a fever, shaking chills, much less urine than usual, or worsening pain in your side or belly, since these can signal a spreading infection or a blocked kidney.

Questions to Ask Your Doctor

  1. 1.Has a biopsy confirmed malacoplakia, and has cancer been ruled out?
  2. 2.Which antibiotic do you recommend, how long will I take it, and how will we know it is working?
  3. 3.Is this affecting my kidneys or the flow of urine, and how will we monitor that?
  4. 4.If I take immune-suppressing medicines, can they safely be adjusted while I am treated?
  5. 5.What follow-up tests will I need, and how often, to catch a recurrence early?

Last reviewed • Oct 2026

Educational content, not medical advice.